期刊文献+

透出液中白介素6和血管生成素受体Tie-2水平与腹膜溶质高转运的关系 被引量:6

Association of interleukin-6 and angiopoietin receptor Tie-2 in dialysate with high peritoneal solute transport in patients undergoing peritoneal dialysis
下载PDF
导出
摘要 目的探讨腹膜透析(腹透)患者透出液中白介素6(IL-6)和血管生成素受体Tie-2水平与腹膜高通透性的关系。方法将60例稳定的持续性非卧床性腹膜透析(CAPD)患者,根据腹膜平衡试验中4 h透出液肌酐与血浆肌酐的比值(D/Pcr)分为L/A组(D/Pcr<0.65,n=39)和H/A组(D/Pcr≥0.65,n=21)。采用ELISA法检测两组患者透出液中IL-6和Tie-2的质量浓度,分析IL-6和Tie-2水平与D/Pcr的相关性。结果 H/A组患者透出液中IL-6和Tie-2的质量浓度分别为(21.71±8.88)pg/mL和(1.23±0.43)ng/mL,均显著高于L/A组患者的(13.94±5.43)pg/mL和(0.95±0.43)ng/mL(P<0.05)。单因素相关分析结果显示:透出液中IL-6和Tie-2水平均与D/Pcr呈正相关(r=0.366,P=0.004;r=0.402,P=0.001);多元逐步回归分析结果显示:透出液中IL-6和Tie-2水平是影响D/Pcr的独立危险因素(β=0.007,P=0.026;β=0.162,P=0.006)。结论腹膜高转运的CAPD患者存在较明显的腹腔局部炎症和血管新生。透出液中IL-6和Tie-2水平是影响腹膜通透性的独立危险因素,提示腹腔局部炎症和血管新生与腹膜通透性的改变有关。 Objective To investigate the association of interleukin-6(IL-6) and angiopoietin receptor Tie2 in dialysate with high peritoneal solute transport in patients undergoing peritoneal dialysis.Methods Sixty patients undergoing stable continuous ambulatory peritoneal dialysis(CAPD) were included,and were divided into two groups according to the values of dialysis/plasma creatinine(D/Pcr) at 4 h in peritoneal equilibration test.D/Pcr was 〈0.65 in L/A group(n=39),while that was ≥0.65 in H/A group(n=21).The mass concentrations of IL-6 and Tie-2 in dialysate of two groups were measured by ELISA,and the association of IL-6 and Tie-2 with D/Pcr was explored.Results The mass concentrations of IL-6 and Tie-2 in dialysate of H/A group were(21.71±8.88) pg/mL and(1.23±0.43) ng/mL respectively,and were significantly higher than those of L/A group,which were(13.94±5.43) pg/mL and(0.95±0.43) ng/mL respectively(P〈0.05).Univariate correlation analysis indicated that both IL-6 and Tie-2 in dialysate were positively related to D/Pcr(r=0.366,P=0.004;r=0.402,P=0.001),and multiple stepwise regression analysis revealed that IL-6 and Tie-2 in dialysate were independent risk factors for D/Pcr(β=0.007,P=0.026;β=0.162,P=0.006).Conclusion Significant abdominal inflammation and angiogenesis may exist in patients undergoing CAPD with high peritoneal solute transport status.IL-6 and Tie-2 in dialysate are independent risk factors for peritoneal permeability,which indicates abdominal inflammation and angiogenesis may be related to the change of peritoneal permeability.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2012年第6期751-755,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家自然科学基金(30600290) 上海市科委资助项目(044119620 07QA14040 08dz1900501 114119a5900)~~
关键词 白介素6 TIE-2 血管新生 腹膜高通透性 腹膜透析 interleukin-6; Tie-2; angiogenesis; high peritoneal solute transport rate; peritoneal dialysis
  • 相关文献

参考文献22

  • 1Williams JD, Craig KJ, Topley N, et al. Peritoneal dialysis: chan- ges to the structure of the peritoneal membrane and potential for biocompatible solutions[ J ]. Kidney Int Suppl, 2003, 84 : S158 - S161.
  • 2Fusshoeller A. Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis[J]. Pediatr Nephrol, 2008, 23( 1 ) : 19 -25.
  • 3Davies SJ. Longitudinal relationship between solute transport and uhrafihration capacity in peritoneal dialysis patients [J]. Kidney Int, 2004, 66 (6) : 2437 - 2445.
  • 4Rumpsfeld M, McDonald SP,Johnson DW. Higher peritoneal trans- port status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient popula- tions[J]. JAm Soc Nephrol, 2006, 17(1): 271 -278.
  • 5Brimble KS, Walker M, Margetts PJ, et al. Meta-analysis: perito- neal membrane transport, mortality, and technique failure in perito- neal dialysis[J]. J Am Soc Nephrol, 2006, 17(9) : 2591 -2598.
  • 6Lai KN, Lai KB, Lam CW, et al. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis[ J]. Am J Kidney Dis, 2000, 35 (4): 644- 652.
  • 7Fiedler U, Augustin HG. Angiopoietins: a link between angiogene- sis and inflammation [ J ]. Trends Immunol, 2006, 27 (12) : 552 - 558.
  • 8Twardowski ZJ. PET - a simple approach for determining prescrip- tion for adequate dialysis therapy[ J]. Adv Perit Dial, 1990, 6: 186 - 191.
  • 9Pecoits-Filho R, Ara6jo MR, Lindholm B,et al. Plasma and dialy- sate IL-6 and VEGF concentrations are associated with high perito- neal solute transport rate [ J ]. Nephrol Dial Transplant, 2002, 17 (8) : 1480 -1486.
  • 10Pecoits-Filho R, Carvalho M J, Stenvinkel P, et al. Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis[J]. Perit DialInt, 2006, 26(1): 53-63.

二级参考文献21

  • 1袁江姿,钱家麒,方炜,倪兆慧,戴慧莉.可溶性酪氨酸激酶2融合蛋白对肿瘤坏死因子α诱导腹膜血管内皮细胞新生血管能力的影响[J].中华肾脏病杂志,2007,23(7):453-457. 被引量:3
  • 2Saxena R. Pathogenesis and treatment of peritoneal membrane failure. Pediatr Nephrol, 2008, 23: 695-703.
  • 3Witzenbichler B, Maisonpierre PC, Jones P, et al. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem, 1998, 273: 18514-18521.
  • 4Yuan JZ, Fang W, Ni ZH, et al. Peritoneal morphologic changes in a peritoneal dialysis rat model correlate with angiopoietin/Tie-2. Pediatr Nephrol, 2009, 24: 163-170.
  • 5Takagi H, Koyama S, Seike H, et al. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization, Invest Ophthalmol Vis Sci, 2003, 44:393-402.
  • 6Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol, 1995, 147: 9-19.
  • 7Zareie M, Hekking LH, Welten AG, et al. Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo. Nephrol Dial Transplant, 2003, 18: 2629-2637.
  • 8Zareie M, Keuning ED, ter Wee PM, et al. Improved biocompatibility of bicarbonate/lactate -buffered PDF is not related to pH. Nephrol Dial Transplant, 2006, 21: 208-216.
  • 9Wieczorowska-Tobis K, Polubinska A, Schaub TP, et al. Influence of neutral pH dialysis solutions on the peritoneal membrane: a long-term investigation in rats. Perit Dial Int, 2001, 21: S108-S113.
  • 10Mortier S, Faict D, Lameire NH, et al. Benefits of switching from a conventional to a low-GDP bicarbonate/ lactatebuffered dialysis solution in a rat model. Kidney lnt, 2005, 67: 1559-1565.

共引文献5

同被引文献91

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部